The core activity of Rambam AG is the founding and promotion of biotech companies in the field of drug development, particularly through the provision of venture capital, technological support and management expertise. The company focuses on the development of medicines in high-value therapeutic areas such as immunology, oncology, neurology and infectious diseases. Through its platform and network of partners and experts, Rambam AG supports the rapid and efficient development of medicines from discovery to clinical testing.